Tag:
Invus
Latest Headlines
Latest Headlines
Invus invests $550M in Lexicon
New York-based investment firm Invus is purchasing up to $550 million in Lexicon Pharmaceuticals common stock to help finance Lexicon's 10 to 10 program. The 10 to 10 program is an ongoing company
